查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541479

2024-2032 年腸溶軟膠囊市場報告（按類型、應用、配銷通路和地區）

Enteric Softgel Capsules Market Report by Type, Application, Distribution Channel, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年，全球腸溶軟膠囊市場規模達26億美元。這個市場主要由全球老年人口不斷成長、慢性疾病和營養缺乏性疾病患病率上升以及對營養和膳食補充劑的接受度不斷提高所推動。

腸溶軟膠囊市場分析：

主要市場促進因素：日益成長的老年人口，更容易受到胃腸道疾病的影響，正在推動腸溶軟膠囊的需求。另一個重要的促進因素是人們對營養保健品和膳食補充劑的偏好不斷增加，這些保健品和膳食補充劑需要有針對性地輸送到腸道以獲得最佳吸收和有效性。

主要市場趨勢：市場的一個主要趨勢是越來越關注先進的藥物輸送系統。製藥公司正在投資研發，以創造更有效率、更有效的腸溶衣，可以精確控制活性成分的釋放。

地理趨勢：北美和歐洲由於其完善的醫療基礎設施、胃腸道疾病的高盛行率以及對藥物研發的大量投資，在腸溶軟膠囊市場佔有率中佔據主導地位。

競爭格局：腸溶軟膠囊產業的一些主要市場參與者包括Aenova Group GmbH、BASF SE、Catalent, Inc.、Colorcon Inc.、Fuji Capsule Co., Ltd.、Lonza Group AG、Now Health Group, Inc.。 、ProCaps Group、Super Spectrim 和Thermo Fisher Scientific, Inc. 等。他們專注於策略合作、合併和收購，以加強其市場地位並擴大其產品組合。

挑戰與機會：根據腸溶軟膠囊市場概況，主要挑戰之一是嚴格的監管環境，因為確保遵守不同的法規對製造商來說可能是複雜且成本高昂的。然而，人們越來越認知到腸溶軟膠囊在提高藥物生物利用度和患者依從性方面的益處，這為市場成長開闢了新的途徑。

腸溶軟膠囊市場趨勢：

慢性病盛行率不斷上升

腸溶軟膠囊市場的成長主要受到糖尿病、心血管疾病和胃腸道疾病等慢性病盛行率上升的顯著推動。根據美國疾病管制與預防中心的數據，估計美國有 1.29 億人患有至少一種主要慢性疾病，包括心臟病、癌症、糖尿病、肥胖和高血壓。此外，美國十大死因中有五個是可預防和可治療的慢性病，​​或與可預防和可治療的慢性病密切相關。此外，在過去二十年中，盛行率穩定上升，並且預計這種趨勢將持續下去。腸溶軟膠囊可連續、有針對性地釋放藥物，這有利於治療通常需要長期治療的疾病。這些膠囊透過在腸道而不是胃中釋放其內容物，確保藥物在最有效的地方被吸收。這種有針對性的給藥是治療慢性疾病的理想替代方案，因為它可以增強治療效果並減少副作用。隨著人口老化、久坐的生活方式和不斷變化的飲食習慣加劇了全球慢性疾病的負擔，對腸溶軟膠囊和其他複雜的藥物輸送技術的需求可能會越來越大。

人們越來越偏愛營養補充劑

推動腸溶軟膠囊市場收入的另一個因素是消費者對膳食補充劑的興趣日益成長。根據國家醫學圖書館的數據，全球營養保健品和補充劑市場在過去十年中穩步成長，據報道2019 年價值3,530 億美元。以下主題相關的文章：分別是營養保健品或膳食補充品。此外，自2019年11月開始發生的由嚴重急性呼吸症候群冠狀病毒2（SARS-CoV-2）引起的冠狀病毒病（COVID-19）大流行導致膳食補充劑和營養保健品的銷量在2020年初出現更大成長營養保健品領域廣泛使用腸溶軟膠囊來提供維生素、礦物質和其他營養補充劑。這些膠囊具有許多優點，包括提高營養吸收和生物利用度、保護脆弱成分免受胃酸的影響，以及提高客戶便利性和依從性。隨著人們對其健康優勢的認知不斷增強，越來越多的人將營養補充品納入日常生活中。這種趨勢在老年族群和想要使用補充劑來預防或治療醫療問題的注重健康的消費者中尤為突出。

老年人口不斷增加

增加腸溶軟膠囊市場價值的另一個主要方面是老年人口的成長。根據聯合國 (UN) 的數據，全球 65 歲及以上人口預計將增加一倍以上，從 2021 年的 7.61 億增加到 2050 年的 16 億。老年人經常有特殊的醫療保健需求，例如治療多種慢性疾病並需要易於吞嚥、胃腸道友善的藥物。腸溶軟膠囊滿足了這些標準，它提供了一種實用且有效的方法來輸送處方藥和膳食補充劑。這些膠囊的腸溶衣特別有用，因為消化問題在老年族群中更為常見。此外，隨著預期壽命的延長和出生率的下降，世界老年人口正在擴大。腸溶軟膠囊可以提高藥物依從性和治療效果，是預期由於人口結構轉變而需求增加的醫療保健產品之一。

腸溶軟膠囊市場區隔：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據類型、應用和配銷通路對市場進行了分類。

按類型分類：

明膠膠囊

非明膠軟膠囊

明膠膠囊佔大部分市場佔有率

該報告根據類型提供了詳細的市場細分和分析。這包括明膠膠囊和非明膠軟膠囊。根據該報告，明膠膠囊代表了最大的部分。

根據腸溶膠囊市場預測，明膠膠囊因其卓越的生物相容性和吸收性而受到廣泛青睞。明膠源自動物膠原蛋白，是一種易於人體吸收和消化的天然蛋白質。由於其生物相容性，它對於各種消費者來說也是安全的，包括那些胃部敏感或飲食限制的消費者。明膠膠囊也因具有高生物利用度或活性物質有效吸收到血液中的能力而聞名。因此，用於製造軟膠囊的明膠需求不斷增加。根據國家醫學圖書館的數據，2020 年明膠市場規模達到 31.8 億美元，預計到 2024 年將達到 40.8 億美元。

按應用分類：

保健品

藥品

保健品佔業界最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括保健品和藥品。報告顯示，保健品佔最大的市佔率。

市場以保健品為主，主要是因為人們越來越意識到維護整體健康和福祉的價值。根據Research Gate的數據，53.7%的調查參與者根據醫生的建議服用膳食補充劑，28.5%的人自行決定服用，15.9%的人在朋友建議後服用； 87.4%的參與者在藥局購買補充劑。隨著健康產業的發展，越來越多人開始積極關注自己的健康，並尋找有助於增強免疫力、提供重要的營養並預防慢性疾病的補充劑。由於腸溶軟膠囊可以保護脆弱成分免受胃酸的影響，從而改善腸道內的吸收和生物利用度，因此它們是這些營養素的一種有吸引力的輸送選擇。

按配銷通路分類：

超級市場和大賣場

藥局和藥局

網路商店

藥房和藥局是主要的細分市場

該報告根據配銷通路對市場進行了詳細的細分和分析。這包括超市和大賣場、藥局和藥局以及網路商店。報告稱，藥局和藥局是最大的細分市場。

藥房和藥局在市場上佔有重要的市場佔有率。這些分佈廣泛且對消費者友善的零售點為處方藥和營養補充品提供了實用的銷售點。藥劑師可以提供專家指導，顧客經常選擇從藥局購買與健康相關的產品，保證他們的決定是明智的。根據麥肯錫發布的報告，零售連鎖店是四種藥房類型中最大、最普遍的，佔2021 年商店的三分之一和處方收入的約三分之一。個處方藥每年比雜貨店多出約 50%，雜貨店是美國每個零售點第二大處方藥分配商。

按地區分類：

北美洲

美國

加拿大

亞太

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的腸溶軟膠囊市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是腸溶軟膠囊最大的區域市場。

在北美創造有利的腸溶軟膠囊市場前景的一個重要促進因素是慢性疾病盛行率的增加。根據美國國家醫學圖書館的數據，美國 50 歲及以上的人口將從 2020 年的 1.3725 億增加到 2050 年的 2.2113 億，成長 61.11%。到2050年，慢性病患者將從2020年的7152.2萬人增加到1.4266萬人，成長99.5%。普遍存在。腸溶軟膠囊提供藥物的標靶和持續釋放，這對於經常需要長期治療的慢性病患者有益。這些膠囊是治療慢性疾病的建議選擇，因為它們可以增強治療效果並最大限度地減少不良反應。北美的巨大市場佔有率主要歸因於慢性疾病盛行率的上升，這反過來又推動了對高效實用的給藥方法的需求。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。該行業的一些主要腸溶軟膠囊公司包括 Aenova Group GmbH、BASF SE、Catalent, Inc.、Colorcon Inc.、Fuji Capsule Co., Ltd.、Lonza Group AG、Now Health Group, Inc.、ProCaps Group、 Super Spectrim 和Thermo Fisher Scientific, Inc.

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

根據腸溶軟膠囊市場研究報告，主要參與者正在建立策略聯盟和合作夥伴關係以加強其地位。他們也透過與學術機構、研究中心和其他製藥公司的合作進行創新。這些夥伴關係經常導致技術和資訊的交流以及新產品的共同開發，所有這些都極大地增強了企業的競爭優勢。提高產能是腸溶軟膠囊產業頂級競爭對手採用的另一個重要策略。企業可以透過投資新生產設施或改造現有生產設施來提高產能並提高營運效率。此外，企業正在進入新興市場，這些市場對先進醫藥產品的需求不斷上升，這提供了巨大的成長機會。

腸溶軟膠囊市場新聞：

2023年10月，贏創推出了一款功能性、即用型口服膠囊，設計用於臨床前試驗。 EUDRACAP(R) 臨床前腸溶膠囊是一種尺寸非常小的 9 小時（5.1 毫米）技術級膠囊，適合通過臨床前動物模型的胃腸道。腸溶膠囊使製藥公司能夠透過減少臨床前試驗期間的成本、時間和變數來最佳化藥物開發。

2023 年7 月，美國國家醫學圖書館發表了一份報告，介紹了一項使用海藻酸鈉(SA)、羧甲基澱粉(CMS) 和κ-卡拉膠(κ-C) 作為基質材料形成軟膠囊的試驗結果。結果表明，κ-C與CMS和SA具有很強的相互作用，並且κ-C的添加大大改善了膠囊殼的機械性能。因此，本研究為製備腸溶軟膠囊提供了替代配方。

本報告回答的關鍵問題

  • 2023年全球腸溶軟膠囊市場規模是多少
  • 2024-2032年全球腸溶軟膠囊市場的預期成長率是多少
  • COVID-19對全球腸溶軟膠囊市場有何影響
  • 推動全球腸溶軟膠囊市場的關鍵因素是什麼
  • 全球腸溶軟膠囊市場按類型分類是怎樣的
  • 根據應用，全球腸溶軟膠囊市場的細分如何
  • 基於配銷通路，全球腸溶軟膠囊市場的細分如何
  • 全球腸溶軟膠囊市場的重點區域有哪些
  • 誰是全球腸溶軟膠囊市場的主要參與者/公司

本報告回答的關鍵問題

  • 2023年全球腸溶軟膠囊市場規模？ 2024-2032年全球腸溶軟膠囊市場的預期成長率為何？
  • COVID-19 對全球腸溶軟膠囊市場有何影響？
  • 推動全球腸溶軟膠囊市場的關鍵因素是什麼？
  • 全球腸溶軟膠囊市場按類型分類是怎樣的？
  • 根據應用，全球腸溶軟膠囊市場的細分如何？
  • 基於配銷通路，全球腸溶軟膠囊市場的細分如何？
  • 全球腸溶軟膠囊市場的關鍵區域有哪些？
  • 全球腸溶軟膠囊市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球腸溶軟膠囊市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 明膠膠囊
    • 市場趨勢
    • 市場預測
  • 非明膠軟膠囊
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：按應用

  • 保健品
    • 市場趨勢
    • 市場預測
  • 藥品
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按配銷通路

  • 超級市場和大賣場
    • 市場趨勢
    • 市場預測
  • 藥局和藥局
    • 市場趨勢
    • 市場預測
  • 網路商店
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Aenova Group GmbH
    • BASF SE
    • Catalent, Inc.
    • Colorcon Inc.
    • Fuji Capsule Co., Ltd.
    • Lonza Group AG
    • Now Health Group, Inc.
    • ProCaps Group
    • Super Spectrim
    • Thermo Fisher Scientific, Inc.
Product Code: SR112024A4232

The global enteric softgel capsules market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.6 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. The market is primarily driven by the growing global geriatric population, the rising prevalence of chronic medical disorders and nutrient-deficient diseases, and the growing acceptance of nutritional and dietary supplements.

Enteric Softgel Capsules Market Analysis:

Major Market Drivers: The growing geriatric population, which is more susceptible to gastrointestinal conditions is boosting the enteric softgel capsule demand. Another significant driver is the rising preference for nutraceuticals and dietary supplements that need targeted delivery to the intestines for optimal absorption and effectiveness.

Key Market Trends: A key trend in the market is the increasing focus on advanced drug delivery systems. Pharmaceutical companies are investing in research and development to create more efficient and effective enteric coatings that can precisely control the release of active ingredients.

Geographical Trends: North America and Europe dominate the enteric softgel capsules market share due to their well-established healthcare infrastructure, high prevalence of gastrointestinal disorders, and significant investment in pharmaceutical research and development.

Competitive Landscape: Some of the major market players in the enteric softgel capsules industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc. among many others. They are focusing on strategic collaborations, mergers, and acquisitions to strengthen their market position and expand their product portfolios.

Challenges and Opportunities: As per the enteric softgel capsules market overview, one of the main challenges is the stringent regulatory environment as ensuring compliance with varying regulations can be complex and costly for manufacturers. However, the growing awareness of the benefits of enteric softgel capsules in improving drug bioavailability and patient compliance opens new avenues for market growth.

Enteric Softgel Capsules Market Trends:

Growing prevalence of chronic diseases

The enteric softgel capsule market growth is significantly driven by the rising prevalence of chronic diseases like diabetes, cardiovascular disease, and gastrointestinal disorders. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Moreover, over the past two decades prevalence has increased steadily, and this trend is expected to continue. Enteric softgel capsules offer a continuous and targeted release of medication, which is beneficial for treating illnesses that often require long-term treatment. By releasing its contents in the intestines instead of the stomach, these capsules make sure the medication is absorbed where it works best. This targeted administration is a desirable alternative for managing chronic diseases since it can enhance therapeutic outcomes and lessen side effects. With aging populations, sedentary lifestyles, and changing dietary habits contributing to the global burden of chronic diseases, enteric softgel capsules and other sophisticated drug delivery technologies are likely to become more and more in demand.

Increasing preference toward nutritional supplements

Another factor propelling the enteric softgel capsule market revenue is the growing inclination of consumers toward dietary supplements. As per the National Library of Medicine, the global nutraceuticals and supplements market has steadily grown over the past decade and was reported to be worth $353 Billion in 2019. Research in the field has also grown, with over 70,000 published articles available in PubMed relating to nutraceuticals or dietary supplements respectively. Besides, the occurrence of the coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) starting in November 2019 led to an even greater increase in sales of dietary supplements and nutraceuticals in early 2020. The nutraceutical sector uses enteric softgel capsules extensively to provide vitamins, minerals, and other nutritional supplements. These capsules have a number of benefits, including as increased nutrient absorption and bioavailability, shielding delicate components from stomach acids, and improving customer convenience and compliance. More people are including nutritional supplements in their regular routines as awareness of their health advantages develops. This trend is especially prominent among older populations and health-conscious consumers who want to use supplements to prevent or treat medical issues.

Rising geriatric population

Another major aspect increasing the enteric softgel capsule market value is the growing geriatric population. According to the United Nations (UN), the global population aged 65 years or older is expected to be more than double, increasing from 761 million in 2021 to 1.6 billion by 2050. The population aged 80 years or older is growing at an even faster rate. Elderly people frequently have particular healthcare demands, such as managing several chronic illnesses and requiring easy-to-swallow, gastrointestinal-friendly drugs. These criteria are met by enteric softgel capsules, which provide a practical and efficient method of delivering prescription drugs and dietary supplements. These capsules' enteric coating is especially helpful as digestive problems are more common in the elderly population. Additionally, as life expectancy rises and birth rates fall, the world's senior population is expanding. Enteric softgel capsules, which can improve medication adherence and treatment outcomes, are among the healthcare items that are predicted to see an increase in demand as a result of this demographic transition.

Enteric Softgel Capsules Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on type, application and distribution channel.

Breakup by Type:

Gelatin Capsules

Non-Gelatin Softgel Capsules

Gelatin capsules accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the type. This includes gelatin capsules and non-gelatin softgel capsules. According to the report, gelatin capsules represented the largest segment.

As per enteric capsules market forecast, gelatin capsules are widely preferred due to their exceptional biocompatibility and absorption. Derived from animal collagen, gelatin is an easily absorbed and digested natural protein by the human body. It is also safe for a variety of consumers including those with sensitive stomachs or dietary restrictions due to its biocompatibility. Gelatin capsules are also renowned for having a high bioavailability, or the ability of the active substances to be effectively absorbed into the bloodstream. Hence, there is an escalating demand for gelatin for manufacturing softgel capsules. As per National Liabrary of Medicine, the market for gelatin in 2020 reached USD 3.18 Billion and is further expected to reach USD 4.08 Billion by 2024 as forecasted in the same report.

Breakup by Application:

Health Supplements

Pharmaceuticals

Health supplements hold the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes health supplements and pharmaceuticals. According to the report, health supplements accounted for the largest market share.

The market is dominated by health supplements primarily due to the increasing awareness of the value of preserving general health and wellbeing. According to the Research Gate, 53.7 % of the participants of the survey took dietary supplements upon the doctor's advice, 28.5 % took them with their own decision, and 15.9 % took them after friend advice; 87.4 % of the participants bought supplements in the pharmacy. As the wellness sector grows, more people are taking an active role in their health and looking for supplements that help boost immunity, deliver vital nutrients, and stave against chronic illnesses. As enteric softgel capsules can shield delicate components from stomach acids, improving absorption and bioavailability in the intestines, they are an appealing delivery option for these nutrients.

Breakup by Distribution Channel:

Supermarkets and Hypermarkets

Pharmacy and Drug Stores

Online Stores

Pharmacy and drug stores represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes supermarkets and hypermarkets, pharmacy and drug stores, and online stores. According to the report, pharmacy and drug stores represented the largest segment.

Pharmacy and drug stores hold a significant market share in the market. These widely dispersed and consumer-friendly retail locations offer a practical point of sale for prescription drugs and nutritional supplements. Pharmacists can offer expert guidance, customers frequently choose to purchase health-related products from pharmacies, guaranteeing that their decisions are well-informed. As per the report published by Mckinsey, retail chains are the largest and most prevalent of the four pharmacy types, representing a third of stores and about a third of prescription revenues in 2021. On a per-store basis, retail chains dispense approximately 138,000 prescriptions annually about 50 percent more than grocers, the next largest prescription dispensers per retail location in US.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest enteric softgel capsules market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for enteric softgel capsules.

An important driver creating a favorable enteric softgel capsules market outlook in North America is the increasing prevalence of chronic disorders. As per National Library of Medicine, the number of people in the United States aged 50 years and older will increase by 61.11% from 137.25 million in 2020 to 221.13 million in 2050.Of the population 50 years and older, the number with at least one chronic disease is estimated to increase by 99.5% from 71.522 million in 2020 to 142.66 million by 2050. Owing mostly to aging populations and lifestyle choices, conditions like diabetes, cardiovascular illnesses, and gastrointestinal ailments are prevalent in the area. Enteric softgel capsules provide targeted and sustained release of medications, which is beneficial for patients with chronic conditions who often need long-term treatment. These capsules are a recommended option for managing chronic diseases since they enhance therapeutic outcomes and minimize adverse effects. The substantial market share of North America is mostly attributed to the rising prevalence of chronic illnesses, which in turn drives demand for efficient and practical drug delivery methods.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major enteric softgel capsules companies in the industry include Aenova Group GmbH, BASF SE, Catalent, Inc., Colorcon Inc., Fuji Capsule Co., Ltd., Lonza Group AG, Now Health Group, Inc., ProCaps Group, Super Spectrim and Thermo Fisher Scientific, Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

As per enteric softgel capsules market research report, key players are establishing strategic alliances and partnerships to strengthen their position. They are also innovating through collaboration with academic institutions, research centers, and other pharmaceutical firms. These partnerships frequently result in the exchange of technology and information as well as the co-development of new goods, all of which greatly strengthen a business's competitive advantage. Increasing production capacity is yet another important tactic used by top competitors in the enteric softgel capsule industry. Businesses can boost production capacity and boost operational efficiency by investing in new production facilities or renovating existing ones. Moreover, companies are entering emerging markets, where the demand for advanced pharmaceutical products is rising, which is providing significant growth opportunities.

Enteric Softgel Capsules Market News:

In October 2023, Evonik launched a functional, ready-to-fill oral capsule designed for use in preclinical trials. EUDRACAP(R) preclinic enteric is a very small size 9h (5.1 mm), technical-grade capsule suitable for passing through the gastrointestinal tract of preclinical animal models. The enteric-coated capsule enables pharmaceutical companies to optimize drug development by reducing cost, time, and variables during preclinical trials.

In July 2023, National Library of Medicine published a report stating results from a trial where sodium alginate (SA), carboxymethyl starch (CMS) and κ-carrageenan (κ-C) were used as matrix materials to form softgel capsules. The results showed that κ-C had strong interaction with CMS and SA, and the mechanical properties of capsule shell were greatly improved by the addition of κ-C. Therefore, the study provided an alternative formula for preparing enteric soft capsules.

Key Questions Answered in This Report

  • 1. What was the size of the global enteric softgel capsules market in 2023?
  • 2. What is the expected growth rate of the global enteric softgel capsules market during 2024-2032?
  • 3. What has been the impact of COVID-19 on the global enteric softgel capsules market?
  • 4. What are the key factors driving the global enteric softgel capsules market?
  • 5. What is the breakup of the global enteric softgel capsules market based on the type?
  • 6. What is the breakup of the global enteric softgel capsules market based on the application?
  • 7. What is the breakup of the global enteric softgel capsules market based on the distribution channel?
  • 8. What are the key regions in the global enteric softgel capsules market?
  • 9. Who are the key players/companies in the global enteric softgel capsules market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Softgel Capsules Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Gelatin Capsules
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Gelatin Softgel Capsules
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Health Supplements
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pharmaceuticals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Supermarkets and Hypermarkets
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmacy and Drug Stores
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aenova Group GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 BASF SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Catalent, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Colorcon Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Fuji Capsule Co., Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Lonza Group AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Now Health Group, Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 ProCaps Group
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Super Spectrim
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Thermo Fisher Scientific, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Softgel Capsules Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Softgel Capsules Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Enteric Softgel Capsules Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Enteric Softgel Capsules Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Enteric Softgel Capsules Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Enteric Softgel Capsules Market: Breakup by Distribution Channel (in %), 2023
  • Figure 7: Global: Enteric Softgel Capsules Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Enteric Softgel Capsules (Gelatin Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Enteric Softgel Capsules (Gelatin Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Enteric Softgel Capsules (Non-Gelatin Softgel Capsules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Enteric Softgel Capsules (Health Supplements) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Enteric Softgel Capsules (Health Supplements) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Enteric Softgel Capsules (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Enteric Softgel Capsules (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Enteric Softgel Capsules (Supermarkets and Hypermarkets) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Enteric Softgel Capsules (Pharmacy and Drug Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Enteric Softgel Capsules (Online Stores) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Enteric Softgel Capsules (Online Stores) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: United States: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: United States: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Canada: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Canada: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Asia-Pacific: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Asia-Pacific: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: China: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: China: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Japan: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Japan: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: India: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: India: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: South Korea: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: South Korea: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Australia: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Australia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Indonesia: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Indonesia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Others: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Europe: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Europe: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Germany: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Germany: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: France: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: France: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: United Kingdom: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: United Kingdom: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Italy: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Italy: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Spain: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Spain: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Russia: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Russia: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Latin America: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Latin America: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Brazil: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Brazil: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Mexico: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Mexico: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Middle East and Africa: Enteric Softgel Capsules Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Middle East and Africa: Enteric Softgel Capsules Market: Breakup by Country (in %), 2023
  • Figure 70: Middle East and Africa: Enteric Softgel Capsules Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Global: Enteric Softgel Capsules Industry: SWOT Analysis
  • Figure 72: Global: Enteric Softgel Capsules Industry: Value Chain Analysis
  • Figure 73: Global: Enteric Softgel Capsules Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Softgel Capsules Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Enteric Softgel Capsules Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Enteric Softgel Capsules Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Enteric Softgel Capsules Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
  • Table 5: Global: Enteric Softgel Capsules Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Enteric Softgel Capsules Market: Competitive Structure
  • Table 7: Global: Enteric Softgel Capsules Market: Key Players